|
|
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
Franck Morschhauser
,
Nicolas Mounier
,
Catherine Sebban
,
Pauline Brice
,
Phillippe Solal-Celigny
et al.
Journal articles
hal-00744246v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
Loic Ysebaert
,
Roch Houot
,
Ibrahim Yakoub-Agha
,
Franck Morschhauser
,
Charles Herbaux
et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles
hal-01290424v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency
Hélène Coignard-Biehler
,
Nizar Mahlaoui
,
Benoît Pilmis
,
Vincent Barlogis
,
Pauline Brosselin
et al.
Journal articles
hal-02377907v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access program.
J Dupuis
,
P Brice
,
S François
,
Loic Ysebaert
,
S de Guibert
et al.
Journal articles
hal-01162051v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program
Aurore Perrot
,
Hélène Monjanel
,
Reda Bouabdallah
,
Philippe Quittet
,
Clémentine Sarkozy
et al.
Journal articles
hal-01259439v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Emmanuel Bachy
,
Roch Houot
,
Franck Morschhauser
,
Anne Sonet
,
Pauline Brice
et al.
Journal articles
hal-00933219v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
Franck Morschhauser
,
Steven Le Gouill
,
Pierre Feugier
,
Sarah Bailly
,
Emmanuelle Nicolas-Virelizier
et al.
Journal articles
hal-02586078v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|